Dr Shuqian Jing, founder, Chairman and CEO of Gmax Biopharm, an innovative biotech company headquartered in Hangzhou, shares how his experiences at global biopharma companies like BMS and Amgen inspired him to create his own biotech company; Gmax’s focus on G protein-coupled receptor (GPCR) therapeutic antibodies; the exciting pipeline the company has in metabolic and cardiovascular diseases and cancer; as well as their highly productive and unique ‘bibody’ technology platform.
In general, our management team is more familiar with the European and US markets, but we are certainly not going to neglect the China market.
